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Copyright © 200? JCBN Summary Because rheumatoid arthritis (RA), an autoimmune disease, the patients often
recognize side-effects due to the medication, alternative therapeutic strategies might potentially
offer a clinical advantage. We evaluated the effect of nucleoprotein from salmon soft roe on
animal model of arthritis. Mice transgenic for human T-cell leukemia virus type I (HTLV-1
Tg) were divided into three experimental groups and supplemented on either nucleoprotein-
free (nonNP), or 0.6% or 1.2% nucleoprotein mixed (NP0.6 or NP1.2) diet for 3 months. The
mice were evaluated arthritis by morphology, and measured with rheumatoid factor (RF).
Moreover, macrophages and oxidative metabolites were assessed in the ankle and/or serum.
Anti-oxidative potentials in nucleoprotein were determined with biological anti-oxidative
potential (BAP) test, and electron spin resonance (ESR) analysis. NonNP-diet HTLV-1 Tg mice
increased an arthritis symptoms and RF. The symptoms were ameliorated in NP-diet groups.
Macrophages detected by F4/80 staining, and oxidative metabolites in the serum and/or joints
were clearly decreased in 1.2% NP-diet HTLV-1 Tg mice. Nucleoprotein and DNA-nucleotide,
but less protamine, had direct anti-oxidative potency with BAP test and/or ESR in vitro. These
observations suggest that dietary nucleoprotein ameliorates arthritis symptoms in HTLV-1 Tg
mice and offers hope as an alternative treatment for this debilitating medical condition.
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Introduction
Rheumatoid arthritis (RA) is an autoimmune systemic
inflammatory disorder affecting ~1% of the world’s popula-
tion. RA is characterized by inflammation of synovial
tissues in multiple joints, destruction of cartilage and bone,
and joint deformation and enlargement [1]. The patients often
develop auto-antibodies and/or cellular immunity against
various self-substances, including immunoglobulin G (IgG),
also known as rheumatoid factors (RF) [2], type II collagen
(IIC) [3,  4], and heat shock protein (HSP) [5, 6]. RF is
accumulated in the joints and it is shown to enhance infiltra-
tion of inflammatory cells such as monocytes and lympho-
cytes. These in turn activate innate immune responses,
resulting in elevation of pro-inflammatory cytokines and
reactive oxygen species (ROS) in the synovial spaces and
surrounding blood vessels. Synergistic responses are known
to induce proliferation of the synovial membranes, causing
arthritic deterioration resulting in a decrease in the joint
functions [7–10].H. Ohtaki et al.
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Clinical therapies for RA have been typically included
medications such as disease-modifying anti-rheumatic drugs,
anti-inflammatory agents, and immunosuppressants, and/or
surgeries such as synovectomy. However, because the RA
patients often recognize side-effects due to the medications,
development of alternative approaches to be delayed the
progression of the disease offers an attractive prospect.
Salmon is currently known as one of the most widely
consumed fish in the world. According to the Japanese
government, catch of salmon in 2006 was 219,000 metric
tons, with the amount of soft roe associated with this catch
thought to be an account for 5,000 metric tons. However,
the fish soft roe is rarely used as food, largely because of
difficulties associated with its processing. The soft roe
usually serves only as a component of organic fertilizer
and a feeds for domestic animals and farmed fish. The fish
soft roe contains mostly nucleoprotein which mainly consists
of a mixture of DNA-nucleotide (DNA-nu) (38%) and
protamine (56%). Oral supplement of nucleotides has shown
to influence the cellular metabolism, proliferation, differen-
tiation and apoptosis, probably by acting as mediators of
signal transduction [11–13]. Dietary nucleotides are also
known to influence immune responses through type 1 and
type 2 helper T (Th1 and Th2) cells [13–16], and DNA
containing the base arrangement, TTAGGG has proven
effective in the prevention or treatment of a variety of organ-
specific and systemic autoimmune diseases, including
arthritis in mouse models [17, 18]. A study has reported a
possible anti-oxidative potential of nucleic acids [19].
Another main comportment, protamine is a protein which
contains high levels of arginine [20]. Dietary protamine has
been shown to prevent positively charged antigen amidated
bovine serum albumin-induced arthritis due to its cationic
properties [21].
Based on the line of evidences, it appears that nucleo-
protein is an easily available natural product and may prove
effective as an alternative medication for prevention or
remedy of autoimmune diseases such as RA. However, to
date, the nutritional significance, efficacy, and underlying
mechanism of action on nucleoprotein remain poorly under-
stood.
Previously, Iwakura et al. have reported the development
of a transgenic (Tg) mouse carrying the env-pX region of
HTLV-1, the etiologic agent of adult T-cell leukemia [22].
The histopathology observed in these Tg mice resembles
human RA in some respects, such as showing the marked
synovial and periarticular inflammations with articular
erosion caused by invasion of granulation tissues. The
HTLV-1 Tg mice also develop autoimmunity and show the
signs of arthritis in multiple joints as early as 4 weeks of age.
Depending on background, by 3 months of age 60% (BALB/
c background) or 20% (C3H/HeN background) of the mice
are affected [23].
In this study, we examined the dietary effect of nucleo-
protein derived from salmon soft roe on progression of the
arthritis in HTVL-1 Tg mice. Our results revealed that the
pathological symptoms were ameliorated in the nucleo-
protein additive chow diet HTVL-1 Tg mice, and suggested
that anti-oxidative property in nucleoprotein might partici-
pate partially the amelioration of the arthritis as a putative
mechanism.
Materials and Methods
Animals
HTLV-1 Tg mice, originally produced by injecting the
LTR-env-pX-LTR region of the HTLV-1 genome into a
(C3H/HeN × C57BL/6J) F1 ovum [22], were backcrossed
to BALB/c mice (Sankyo Lab, Tokyo, Japan) for at least 10
generations before being used experimentally. These mice
start to develop arthritis spontaneously at around 4 weeks
of age, with 60% and 80% of the animals being affected at
3 and 6 months of age, respectively. All experimental proce-
dures were approved by the Institutional Animal Care and
Use Committee of the Showa University (#04116, 05092,
06092, and 07050). The mice were maintained under
specific pathogen-free conditions in the animal facility of
Showa University.
Experimental diets and design
The experimental chows were produced by Crea Japan
(Tokyo, Japan). The chows based on an artificially formu-
lated nucleoprotein-free chow (non NP) and that were
supplemented with either 0.6% or 1.2% nucleoprotein in
non NP (NP0.6 or NP1.2 chow, respectively) extracted from
salmon soft roe (Table 1).
Male HTLV-1 Tg (total 84) and the wild-type (total 83)
littermates were used for the study. The animals were
divided into three experimental groups: non NP (n = 43 of
HTLV-1 Tg and 34 of wild-type, respectively), NP0.6
Table 1. Composition of the experimental chow
% (w/w)
Experimental chow
Non-NP 0.6% NP 1.2% NP
Casein 24.5 24.5 24.5
Cornstarch 45.5 44.9 44.3
G r a n u l a t e d  s u g a r 1 01 01 0
C o r n  o i l 666
Crystal cellulose 3 3 3
Cellulose powder 2 2 2
α- S t a r c h 111
Vitamin mixture 1 1 1
Mineral mixture 7 7 7
Nucleoprotein — 0.6 1.2Nucleoprotein Diet Ameliorates Arthritis
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(n = 21 and 23) or NP1.2 (n = 20 and 26). The experimental
chows (non NP, NP0.6 or NP1.2) were given for 3 months
from 6 to 18 weeks of age. During the periods, the animals
were weighed and measured paw thickness every 2 weeks.
At the end of the 3 months, they were anesthetized with
sodium pentobarbital (50 mg/kg, i.p.) and in some cases
blood samples were collected from the right ventricle for
measurement of RF and oxidative metabolites. All animals
were subsequently perfused transcardially with saline,
followed by 10% buffered formalin for preparing paraffin
sections or by 2% paraformaldehyde for preparing frozen
sections (Fig. 1A).
Measurement of paw swelling
The thicknesses of the wrist and ankle joints were
measured with electron micrometer calipers (QUICK mini
PK-1012; Mitutoyo, Kanagawa, Japan). The long and short
axes of the joints were each measured 3 times, and the
average was calculated. The mean thickness of the joints
was then corrected by body weight, and experimental paw
swelling score was calculated as a percentage of joint
thickness at 6 weeks of age. Score 0 was 100% or less, Score
1 was from 100% to less than 110%, Score 2 was from 110%
to less than 120%, and Score 3 was 120% or more. HTLV-1
Tg (n = 39, 18 and 20 for the non NP, NP0.6 and NP1.2 diet
groups, respectively) and wild-type (n = 10, 8 and 18,
respectively) mice were assessed.
Enzyme immunoassay
Serum obtained from 18 weeks of age was determined the
level of RF using mouse IgG Rheumatoid Factor ELISA
KIT (AKRRG-101, Shibayagi, Gunma, Japan), according to
the manufacturer’s instructions. The data are presented as
units (U)/ml, with one unit representing the titer against
1 mg/ml mouse IgG.
Morphological evaluation
The limbs (n = 10–16) were trimmed the skin and
muscles, decalcified in 1.0% formic acid for 7 days and
paraffin-embedded. The limbs were cut into 4-μm-thickness
sections in the longitudinal axis for histological examina-
tion. The sections were stained with hematoxylin-eosin (HE)
and toluidine blue (TB) and histopathologically evaluated
graded on a scale of 0–4 in the wrist and ankle joints as
previously described [24]. Grade 0 was representing no
observed abnormalities. Grade 1 changes were characterized
by proliferation of synovial lining cells, grade 2 by infiltra-
tion of inflammatory cells, grade 3 by the destruction of
cartilage and bone, and grade 4 by the formation of lym-
phoid follicles and vascular changes (Fig. 1B). An investi-
gator (S.Y) who was unaware of the dietary group to which
each animal belonged determined the morphological scores.
Immunohistochemistry
The fixed limbs (n = 3–4 mice per group) were decalci-
fied in 14% EDTA for 7 days at 4°C. After washing with
0.1 M phosphate buffer (PB; pH 7.2), the limbs were
immersed in 0.1 M PB containing 20% sucrose for 2 days,
and embedded in OCT compound (Sakura Finetechnical,
Tokyo, Japan). The sections (8 μm-thickness) were applied
for immunostaining. After treatment H2O2 and 5% normal
horse serum, the sections incubated with polyvalent goat
anti-mouse IgG antibody (1:320,000; Sigma, St Louis, MO),
rat anti-F4/80 antibody (1:500; BMA, Augst, Switzerland),
or rabbit anti-3-nitrotyrosine (3-NT) antibody (1:500, Up-
state Biotechnology, Lake Placid, NY). The sections were
Fig. 1. Schematic diagram of the present study. (A) Diagram
of animal study. Artificial experimental chows (see
Table 1) are given for 3 months from 6 weeks of age.
Body weight and paw swelling are measured every 2
weeks. Blood and histological analysis are carried out
18 weeks of age. (B) Histological criteria of arthritis
according to previous paper [24]. (C) Representative
images of wave pattern of 1O2 in present/absent of
nucleoprotein. The highest peak of 1O2 generated by rose
bengal is recorded without nucleoprotein (0 μg/ml,
upper), but the height are decreased with nucleoprotein.
(a) is peak of manganese which is internal control. (b) is
peak of 1O2. The relative 1O2 generation was calculated
by (b)/(a).H. Ohtaki et al.
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then rinsed and incubated with biotinylated horse anti-goat
IgG (1:200, Vector, Burlingame, CA), rabbit anti-rat IgG
(1:200, Vector), or goat anti-rabbit IgG (1:200, Santa Cruz)
for 2 h, respectively. The reaction was visualized using an
avidin/biotin complex (Vector) with diaminobenzidine
(DAB; Vector) as a chromogen. Controls followed the same
protocol except that tissues were incubated without the
primary antibodies.
Determination of oxidative metabolite
An oxidative metabolite as a marker for oxidative stress
in serum was determined by a commercial kit, colorimetric
determination of reactive oxygen metabolites test (d-ROMs
test) using free radical electron evaluator (FREE, Health &
Diagnostics, Naples, Italy). The number of samples in non
NP-, NP0.6-, and NP1.2 diet HTLV-1 Tg mice were 19, 11
and 16, respectively.
Briefly, serum samples (20 μl) were dissolved at 37°C in
acetate buffer (pH 4.8) containing FeCl2. The solution was
then mixed gently, and 20 μl of chromogenic mixture con-
taining an aromatic alkyl-amine were added. After incuba-
tion for 5 min at 37°C, the production of the pink aromatic
derivative was measured at 546 nm according to the reaction
as follows:
R-OOH + Fe2+ → R-O￿ +F e 3+ +O H −
R-O￿ +A - N H 2 → R-O– + [A-NH2￿]+ (for alkoxy radicals)
R-OOH + Fe3+ → R-OO￿ +F e 2+ +H +
R-OO￿ +A - N H 2 → R-OO− + [A-NH2￿]+ (for peroxy radicals)
R-OOH; hydroxyperoxides, R-O￿; alkoxy radicals, OH;
hydroxyradical, A-NH2; aromatic amine, [A-NH2￿]+; pink-
colored aromatic derivative, R-OO￿, peroxy radicals.
The results were expressed as unit (U). One unit coincided
with the oxidative potentials of 0.08 mg H2O2/dl.
Assay of biological antioxidant potential test (BAP test) of
NP in vitro
An antioxidant potential of nucleoprotein was measured
as a commercial kit, BAP test, using FREE according to
instruction manual with minor modification. In brief,
nucleoprotein, or DNA-nucleotide or protamine both of
which is a component of nucleoprotein was mixed well with
distilled water. The aliquots (10 μl) were mixed with
reactive solution and the absorbance determined at 510 nm
immediately prior to initiation of the reaction. The mixture
was then incubated for 5 min at 37°C. After centrifuging at
4,000 × g for 2 min to remove insoluble matter, the post-
reaction absorbance of the mixture was measured at 510 nm.
Under these conditions, the solution loses color, the intensity
of this chromatic change being directly proportional to the
ability of the incubated sample to reduce ferric ions to
ferrous ions (μmol/liter) as follows:
FeCl3 + AT (uncolored) → FeCl3 – AT (colored)
FeCl3 − AT (colored) + BP (e−) → 
FeCl2 + AT (uncolored) + BP
FeCl3; ferric chloride, AT (uncolored); a thiocyanate
derivative (uncolored), FeCl3 − AT (colored); the colored
complex of ferric chloride with the thiocyanate derivative,
BP (e−); a sample barrier with reducing/electron donating/
antioxidant activity against ferric ions, BP; the oxidized
from of BP (e−), FeCl2; the ferrous chloride obtained by the
reducing activity of BP (e−).
ESR analysis of NP
To identify sort of ROS scavenged by nucleoprotein, we
carried out ESR analysis. Singlet oxygen (1O2) was generated
by a photosensitization reaction with rose bengal (Wako,
Tokyo, Japan). 1O2 was indirectly estimated as the peak
intensity of 2,2,6,6-tetramethyl-4-hydroxy-piperidinyloxy
(4-OH TEMPO) radical produced by the oxidation of
2,2,6,6-tetramethyl-4-hydroxy-piperidine (4-OH TEMP) [25,
26] with 1O2 (produced by photosensitization with rose
bengal), using ESR (JEOL JES, X-band, 100 kHz modula-
tion frequency, JEOL Corporation, Tokyo Japan) [27]. NP
was dissolved in dimethylslufoxide (DMSO) to the final
concentrations of 5, 10, 20 and 50 μg/ml (n = 3). Samples,
phosphate buffer (pH 7.4, 80 μl), 100 mM 4-OH TEMP
(40 μl) and 200 μM rose bengal (20 μl), and each sample
(in 60 μl DMSO) transferred to quartz ESR cell (Radical
research Company, Tokyo Japan) for recording the ESR
spectrum. The instrument settings were as follows: center
field, 335.5 ± 5 mT; microwave power 5 mW; modulation
amplitude, 0.1 mT; gain, 2.5 × 100.  1O2 generation was
calculated by following formula (Fig. 1C).
1O2 generation = (b)/(a).
(a): peak height (intensity) of manganese as an internal
control.
(b): peak height (intensity) of 1O2 in each sample.
No nucleoprotein which means DMSO only was assigned
as 100%. Radical scavenging activity was determined by
decreasing of 1O2 generation.
Statistical analysis
Data were expressed as mean ± SEM. One-way ANOVA
was performed, followed by Dunnett’s post hoc test for
comparison with vehicle-treated HTLV-1 Tg or wild-type
mice. Values of p<0.05 were considered statistically signifi-
cant.Nucleoprotein Diet Ameliorates Arthritis
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Results
Clinical finding
Artificially formulated experimental chows, nonNP, NP0.6
and NP1.2 were fed to HTLV-1 Tg and wild-type mice for
3 months from 6 to 18 weeks of age. At the end of this
period, the survival rate in the nonNP-, NP0.6- and NP1.2-
diet HTLV-1 Tg groups were 69.8 (30 of 43 mice), 81.0
(17 of 21 mice) and 85.0 (17 of 20 mice) %, respectively,
these differences being insignificant by Kaplan-Meier
survival analysis. The corresponding survival rates in the
nonNP, NP0.6 and NP1.2 groups in wild-type mice were
91.2 (31 of 34 mice), 100.0 (23 of 23 mice), and 96.2 (25 of
26 mice) %, respectively.
As shown in Fig. 2A, at 6 weeks of age corresponding
before diet, the mean body weight of the HTLV-1 Tg mice
(22.4 ± 0.3 g; mean ± SEM) was already less than that of the
wild-type mice (25.4 ± 0.4 g). The body weight of wild-type
mice gradually increased between 32 and 34 g at 18 weeks
of age (no significantly difference in three experimental
groups). The addition of NP could be no influence total
calorie gain or consumption. By contrast, at 18 weeks of age,
the mean body weight of the HTVL-1 Tg mice was
23.8 ± 0.9 g, 25.8 ± 1.3 g, and 26.8 ± 0.7 g in the non NP,
NP0.6 and NP1.2 diet groups, respectively. NP1.2-fed Tg
mice were significantly greater body weight than non NP-fed
one at both 16 (p<0.01) and 18 (p<0.05) weeks of age.
Effect of NP diet on paw swelling
Joint thickness was measured in the different groups of
HTLV-1 Tg and wild-type mice from 6 to 18 weeks of age
(Fig. 2B and C). In the wild-type littermates, each dietary
cohort consistently recorded a paw swelling score of 0.25
or less in both the wrists and ankles, with no significant
differences. In the case of the non NP-diet HTLV-1 Tg mice,
the score gradually increased, and showed maximum at 18
weeks in the wrist (1.13 ± 0.26) and at 16 weeks in the ankle
(1.23 ± 0.24). Each joint of NP-fed groups in Tg mice was
lower scores than that of the non NP-fed Tg mice, with the
wrists and ankles in the NP1.2-fed Tg group being
0.33 ± 0.18 and 0.44 ± 0.18 (p<0.05) at 16 weeks, and
0.25 ± 0.14 (p<0.01) and 0.13 ± 0.09 (p<0.001) at 18 weeks,
respectively.
Improvement of histophathological score with nucleoprotein
Histopathological changes in animals with arthritis were
next evaluated at 18 weeks of age. In Fig. 3A, Representa-
tive images of ankles were shown in wild-type, and non NP
or NP-diet HTLV-1 Tg mice. The ankles of the non NP-fed
HTLV-1 Tg mice showed marked proliferation of synovial
tissues, increases of inflammatory cells, destruction of
cartilage and excessive deformation of bone. Moreover,
the formation of lymphoid follicles and angiogenesis in the
Fig. 2. Changes in body weight and joint swelling in HTLV-1
Tg and wild-type mice. The body weight (A), and thick-
ness of the wrists (B) and ankles (C) are measured for 3
months from 6 to 18 weeks of age. Joint thickness was
showed as the paw swelling score (see Materials and
Methods). NonNP-fed HTLV-1 Tg mice tend to have
low body weights and greater paw swelling scores
during the experimental period. NP1.2-fed HTLV-1 Tg
mice recorded a significantly improved body weight and
paw swelling score at 16 and/or 18 weeks of age. Each
value is expressed as mean ± SE. * p<0.05, ** p<0.01,
*** p<0.001 compared with nonNP-fed HTLV-1 Tg or
wild-type mice (Dunnett’s post hoc test).H. Ohtaki et al.
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proliferation of synovial tissues were also apparent at higher
magnification. The arthritis in NP-fed groups of Tg mice
were clearly improved.
The histopathological scores in the wild-type mice were
mostly 0, only rarely rising as high as 1 (data not shown).
Then, the histopathological features (Fig. 1B) were scored
from 0 (normal) to 4 (severe) in the wrists (Fig. 3B) and
ankles (Fig. 3C) of HTLV-1 Tg mice as described in a
previous study [24]. Eighty percentages of the non NP-fed
Tg mice recorded a score of 3 or more in their wrists and
ankles at 18 weeks of age. In NP0.6-fed Tg animals, the
score of 3 or more was recorded in 53.9% and 74.3% of
cases in the wrists and ankles, respectively, with synovial
tissue proliferation and inflammatory cells also being noted
(Fig. 3A). In the case of NP1.2-diet Tg mice, the histopatho-
logical score was significantly decreased to compare with
the non NP-fed animals, with a score of 3 or more being
recorded in 21.4% (p<0.05) and 25.0% (p<0.05) of wrists
and ankles, respectively. The histopathological scores in the
wild-type mice were mostly 0, only rarely rising as high as 1
(data not shown).
Fig. 3. Histopathological score of arthritic degeneration in the wrists and ankles after NP diet. (A) Typical histopathological images
(HE staining) of the ankles in the nonNP-fed wild-type (wild), and nonNP-, NP0.6- or NP1.2-fed HTLV-1 Tg (Tg) mice. Ankle
in nonNP-fed Tg mice clearly showed proliferation of synovial tissue (asterisks), inflammation and lymph nodes (arrowheads),
and destruction of cartilage and bone (arrows). Eighty percentages of nonNP-fed HTLV-1 Tg mice recorded a score of 3 or 4 in
wrists (B) and ankles (C). The mice fed nucleoprotein additive chow are ameliorated the score in a content-dependent manner.
NP1.2-fed HTLV-1 Tg mice had a significantly reduce the score compared with nonNP-fed animals (p<0.05). Numbers in the
columns indicate the incidence (%).Nucleoprotein Diet Ameliorates Arthritis
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Decreases of serum and tissue IgG (RF)
Serum RF was measured in HTLV-1 Tg and the wild-type
mice at 18 weeks of age (Fig. 4A). There were no significant
differences the serum RF levels in the non NP-, NP0.6- and
NP1.2-fed wild-type animals. In contrast, the level in the
non NP-fed HTLV-1 Tg was 22.8 ± 2.1 U/ml (n =1 1 ) ,
approximately 1.5-fold higher than that in the wild-type
mice. In NP0.6- and NP1.2-fed HTLV-1 Tg mice, the value
decreased to 19.4 ± 2.4 (n = 12) and 16.1 ± 1.5 U/ml
(n = 15, p<0.05 vs non NP-fed HTLV-1 Tg one), respec-
tively.
The incremental changes in serum RF levels were verified
by mouse IgG immunostaining in the joints (Fig. 4B). Few
IgG-positive reactions were observed in the ankles of non
NP-fed wild-type animals. However, intense and widespread
immunoreactivity was noted in the ankles of the non NP-fed
HTLV-1 Tg animals. The observed IgG-positive reactions
were most obvious around the bones, especially in the
synovial tissues, but were less apparent in the muscles. The
IgG-like immunoreactivity was decreased in NP0.6- and
NP1.2-fed animals, with the ankle joints of NP1.2-fed
HTLV-1 Tg mice appearing similar to those of the wild-type
mice. These findings were mirrored by those obtained in the
wrist joints (data not shown).
Decreases in the monocytes infiltration with NP
Immunostaining for F4/80 which is a marker for macro-
phage was carried out in order to further investigate the
monocytes infiltration in joints as an inflammatory response
(Fig. 5). F4/80 immunoreactivity was observed in the bone
cavity of the non NP wild-type mice due to the presence of
hematopoietic cells in the bone marrow, but less labeled in
the synovial cavity and surrounding area in the ankle joint.
The number and intensity for F4/80 immunopositive cells
were prominent in these regions in the non NP-fed HTLV-1
Tg mice (Fig. 5A). Higher magnification images revealed
small round and/or amorphous shaped F4/80-positive
cells clustered in the synovial membrane. F4/80 immuno-
reactivity was also increased on the surface of the deformed
bone. In mice with the supplement of nucleoprotein, the F4/
80-positive responses were clearly reduced in a nucleo-
protein dose-dependent manner (Fig. 5B and C).
We measured the serum levels of IL-6 and IL-17 at 18
weeks of age to further investigate inflammatory responses.
IL-6 and IL-17 levels increased in HTLV-1 Tg mice
compared with their wild-type counterparts. However, no
significant differences were recorded as a result of supple-
ment of nucleoprotein in HTLV-1 Tg one. (data not shown).
Suppression of oxidative stress by NP
It is supposed that the oxidative stress participated in the
arthritis. Therefore we measured a serum oxidative metabo-
lite with dROMs test, and a tissue oxidative metabolite, 3-
NT. dROMs test represents the metabolites for peroxy- and
alkoxyl-radicals, whereas 3-NT is the oxidative metabolite
of L-tyrosine by peroxynitrite which is reactant between
superoxide anion and nitric oxide. As shown in Fig. 6A,
serum dROMs value in the non NP-fed HTLV-1 Tg mice
Fig. 4. Dietary effect of nucleoprotein on RF (as IgG) in HTLV-
1 Tg (Tg) and wild-type (wild) mice. (A) RF level in
serum of nonNP-fed HTLV-1 Tg mice was higher than
that of the wild-type mice. NP-fed groups displayed a
dose-dependent decrease in serum RF, with NP1.2-fed
HTLV-1 Tg mice recording a significant decrease in the
level of RF compared with that in the nonNP-fed
group (p<0.05). Each value is shown as mean ± SE. (B)
Immunohistochemical staining of mouse IgG in the
ankles of nonNP-fed wild-type (wild), and nonNP-,
NP0.6- or NP1.2-fed HTLV-1 Tg (Tg) mice. Little
reactivity was seen in the ankles of wild-type mice. By
comparison, intensity of IgG immunoreaction in the
ankles was markedly stronger in nonNP-fed HTLV-1 Tg
mice, but was decreased in NP0.6- or NP1.2-fed groups.
The IgG-positive reactions in the nonNP-fed HTLV-1 Tg
mice were observed in the synovial tissue (*) and, to a
lesser extent, in the bone (**) and muscles (***).H. Ohtaki et al.
J. Clin. Biochem. Nutr.
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was 159.9 ± 9.9 U (n = 19). This level decreased dose-
dependently in the NP0.6- and NP1.2-fed HTLV-1 Tg
animals to 139.2 ± 10.4 U (n = 11) and 125.2 ± 7.1 U
(n = 16, p<0.05 vs non NP Tg). Immunostaining for 3-NT in
the ankles verified the increase in oxidative stress in the non
NP-fed HTLV-1 Tg mice (Fig. 6B) and the positive reaction
was clearly located in the hyaline cartilage. However, no
such immunoreactivity was observed in the NP1.2-fed
HTLV-1 Tg and non NP-fed wild-type mice.
Anti-oxidant potential of NP in vitro
Finally, we determined anti-oxidative potential of nucleo-
protein in vitro whether the oxidative stress was scavenged
by nucleoprotein or not. In addition, to determine what
component is required for the radical scavenging, we carried
out the BAP test against the main component of nucleo-
protein, DNA-nu and protamine as well as nucleoprotein
(Fig. 7A). A nucleoprotein suspension which includes
approximately 38% DNA-nu and 56% protamine displayed
direct radical scavenging ability in a dose-dependent
manner. The BAP value of nucleoprotein was significantly
increased at 5.0 μg/ml or more. DNA-nu was higher BAP
value than nucleoprotein, and showed significantly increase
at 2.5 μg/ml or more, probably for high DNA-nu content.
Protamine also exerted significantly anti-oxidative capability
at 75 μg/ml or more while it was obviously less than the
others. DNA-nu looks higher radical scavenging potential.
However, correcting the content of DNA-nu in nucleo-
protein, both samples show similar radical scavenging
ability. This also indicates the radical scavenging ability
might be due to DNA-nu.
Further analysis by ESR demonstrated that nucleoprotein
could scavenge artificial generated 1O2 in a dose-dependent
fashion (Fig. 1C and 7B). Nucleoprotein decreased 1O2 to
61.20 ± 0.63, 50.14 ± 0.64, 25.17 ± 1.43, and 3.30 ± 0.20%
at 5, 10, 20, and 50 μg/ml, respectively. Nucleoprotein also
could scavenge slightly NO radical and superoxide anion
while the higher NP concentrations (milligrams order) were
required for the significantly difference (data not shown).
Fig. 5. Dietary effects of nucleoprotein on inflammatory responses in HTLV-1 Tg mice. Immunohistochemical staining for a macro-
phage marker, F4/80, in the ankle of nonNP (A)-, NP0.6 (B)- or NP1.2 (C)-fed HTLV-1 Tg mice. A higher magnification
image of the boxed regions is shown in (a) to (f). F4/80 immunoreactivity was clearly observed in the ankles of nonNP-fed
HTLV-1 Tg mice, especially in the synovial membrane (arrows in a and b). The number of labeled cells and the intensity of F4/
80 immunoreactivity decreased in a dose-dependent manner. F4/80 immunoreactivity was reduced or absent in the synovial
membrane of the NP1.2-fed HTLV-1 Tg mice.Nucleoprotein Diet Ameliorates Arthritis
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Discussion
We have demonstrated in the present study that the
artificial chow supplement with nucleoprotein derived
from salmon soft roe suppresses 1) a decline in body weight,
2) joint hypertrophy, 3) an increases in RF level, and 4)
aggravation of arthritis in HTLV-1 Tg mice in a dose-
dependent manner. We have also determined that Tg mice
given nucleoprotein additive chow decreased macrophages
activation or monocyte infiltration in the joints, and oxida-
tive metabolites. The latter effects may appear to result
from the direct radical scavenging ability of nucleoprotein,
especially of DNA-nu.
Iwakura et al. have previously reported that 60% and 80%
of HTLV-1 Tg mice develop RA-like symptoms at 3 and 6
months of age, respectively [22, 23]. In the present study, the
incidence of arthritis in the non NP-fed HTLV-1 Tg animals
had already accounted for 80% at 18 weeks (4.5 months)
of age. This slightly exacerbation of the course of these
symptoms is possibly due to the lack of any nucleoprotein in
the experimental chow. HTLV-1 Tg mice fed nucleoprotein
additive chow significantly improved the clinical manifesta-
tions of the arthritis in a dose-dependent manner. Apparently,
there are no differences in any experimental chow fed wild-
type mice. Privation of nucleoprotein in daily diet might
influence easily in a pathological condition while privation
of it in healthy condition might be less influence.
The main components of nucleoprotein from salmon soft
roe are DNA-nu and protamine. To date, dietary nucleic
acids and nucleotides have been shown to influence optimal
growth, cell functions and the immune responses [13, 28].
Nucleic acids reduce oxidation of linoleic acid in vitro [19],
whereas nucleotide-free diets result in a decrease in cellular
Fig. 6. Dietary effect of nucleoprotein on oxidative stress in
HTLV-1 Tg mice. (A) the mice fed nucleoprotein
additive chows decreased the serum level of oxidative
metabolite measured with ROM test, being significantly
lower in NP1.2-fed HTLV-1 Tg mice than in nonNP-fed
group (p<0.05, Dunnett’s post hoc test). Each value
is shown as mean ± SEM. (B) Immunohistochemical
staining of 3-NT in hyaline cartilage of the ankles in
nonNP-fed wild-type, and nonNP- or NP1.2-fed HTLV-1
Tg (Tg) mice. There was marked 3-NT immuno-
reactivity in the nonNP-fed HTLV-1 Tg group (arrows).
However, few positive reactions were observed in the
nonNP-fed wild-type or NP1.2-fed HTLV-1 Tg mice.
Fig. 7. Nucleoprotein and DNA-nu, but less protamine exert
direct anti-oxidant capacity. (A) Nucleoprotein, DNA-
nu, and protamine suspensions were performed BAP
test with FREE. Nucleoprotein (close bar) and DNA-nu
(gray bar) increase significantly at 5.0 and 2.5 μg/ml or
more, respectively, and show strong anti-oxidative
potential. In contrast, protamine suspension (open bar)
also exerts anti-oxidative potential (75 μg/ml or more),
but is obviously less than the others. Each data is
shown Mean ± SEM (n = 5). *: p<0.05, **: p<0.01,
***: p<0.001 to compare with 0 μg/ml of each group
(Dunnet’s post hoc test). N.D: no data. (B) Quantitative
analysis of 1O2 with several concentration of nucleo-
protein. The height of peak on the 1O2 is decreased in a
dose-dependent manner. Each data is shown Mean ±
SEM (n = 2 – 3). ***: p<0.001 to compare with 0 μg/ml
of each group (Dunnet’s post hoc test).H. Ohtaki et al.
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and humoral immune responses [14,  28,  29] as well as
reduced resistance to bacterial and fungal pathogens [30–
32]. According to the previous reports, we have initially
postulated modification of the immune responses such as
reduction of pro-inflammatory cytokines. However, in
present study, no significant differences were observed on
proinflammatory cytokine levels among the experimental
chow diet although macrophages activation or infiltration in
the joints was clearly decreased. Proinflammatory cytokines
bring about innate activation of macrophages, synovial
tissues and monocytes [22, 33, 34]. The innate activated
inflammatory cells could produce ROS [35–37]. Increases
in oxidative stress have been implicated in the progression
of symptoms in RA sufferers. The anti-RA medications,
Methotrexate and Etanercept reduce oxidative stress and are
associated with an improvement in RA symptoms [38–40].
We therefore shifted our focus to anti-oxidative potential of
nucleoprotein because one previous paper has been reported
to nucleic acids suppress oxidative stress [19]. Our findings
clearly revealed that NP1.2-fed HTLV-1 Tg mice was
significantly less in serum and joint oxidative metabolites
levels compared with non NP-fed HTLV-1 Tg mice. More-
over, in vitro study indicated that nucleoprotein, especially
the component DNA-nu had a free radical scavenging
effect, but protamine was less. Indeed, nucleoprotein could
scavenge mainly 1O2 by ESR analysis. These results suggest
that a preventive mode of action of dietary nucleoprotein
suppresses the oxidative stress and might result in the
prevention of infiltration and/or activation of inflammatory
cells in part. In contrast, there have been reports that
protamine or basic polypeptides such as poly-L-arginine and
poly-L-lysine participate in suppression of arthritis due to its
cationic properties [21]. Protamine or basic polypeptides also
inhibit the activity of synovial phospholipaseA2 patients
with RA [41]. Endothelial cells in the luxuriant capillaries
in the synovial tissues from patients with RA stimulated
synovial cell proliferation. The protamine inhibited the syn-
ovial cell proliferation [42]. These studies lead to support
to the idea that protamine may also act additively or
synergistically with DNA-nu to prevent the progression of
arthritis as well as DNA-nu. We need further to study by
using separated substances of nucleoprotein what comport-
ment of nucleoprotein is responsible for the suppression of
the arthritis and how much the suppression of oxidative
stress contributed to the amelioration of arthritis.
In conclusion, we have provided an excellent use for
nucleoprotein obtained from fish soft roe, which at present
is a huge untapped natural resource and the cost of fish soft
roe is relatively cheap. Nucleoprotein supplement prevented
the progression of arthritis in of HTLV-1 Tg mice in a dose-
dependent fashion. We suggest the radical scavenging effect
of nucleoprotein as a putative mode of action. Our results
also suggest that nucleoprotein supplement might prove
efficacious in the treatment of RA, delaying the progression
of the disease and deferring the need for more traditional
clinical interventions. Nucleoprotein therefore holds consid-
erable promise as an alternative medication for RA sufferers.
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